Ownership Submission
|
FORM 4
|
|
Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b).
|
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
OMB APPROVAL
|
|
OMB Number:3235-0287Expires:January 31, 2005Estimated average burden hours per response...0.5
|
|
|
1. Name and Address of Reporting Person *
|
|
PineBridge GEM II G.P., L.P.
|
|
2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [IBEX]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
_____ Director
|
_____ 10% Owner
|
|
_____ Officer (give title below)
|
_____ Other (specify below)
|
|
|
|
|
(Last)
|
(First)
|
(Middle)
|
|
65 EAST 55TH STREET
|
|
3. Date of Earliest Transaction (Month/Day/Year)
|
(Street)
|
|
NEW YORK
|
NY
|
10022
|
|
4. If Amendment, Date Original Filed(Month/Day/Year)
|
6. Individual or Join/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
|
|
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
|
|
1.Title of Security
|
2. Transaction Date (Month/Day/Year)
|
2A. Deemed Execution Date, if any (Month/Day/Year)
|
3. Transaction Code
|
4. Securities Acquired (A) or Disposed of (D)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
|
6. Ownership Form: Direct (D) or Indirect (I)
|
7. Nature of Indirect Beneficial Ownership
|
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
(e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
|
2. Conversion or Exercise Price of Derivative Security
|
3. Transaction Date (Month/Day/Year)
|
3A. Deemed Execution Date, if any (Month/Day/Year)
|
4. Transaction Code
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
|
8. Price of Derivative Security
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
|
11. Nature of Indirect Beneficial Ownership
|
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expriation Date
|
Title
|
Amount or Number of Shares
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
|
Director
|
10% Owner
|
Officer
|
Other
|
PineBridge GEM II G.P., L.P.
65 EAST 55TH STREET
NEW YORK, NY10022
|
|
|
|
|
PineBridge Global Emerging Markets Partners II, L.P.
65 EAST 55TH STREET
NEW YORK, NY10022
|
|
|
|
|
Leone John
65 EAST 55TH STREET
NEW YORK, NY10022
|
|
|
|
|
Clowe Kevin
65 EAST 55TH STREET
NEW YORK, NY10022
|
|
|
|
|
Mellinger Pierre
65 EAST 55TH STREET
NEW YORK, NY10022
|
|
|
|
|
Signatures
|
/s/ John Leone - for PineBridge GEM II G.P., L.P., By: PineBridge GEM II G.P., Co, its general partner, By: John Leone, Vice President
|
2024-09-17
|
|
**Signature of Reporting Person
|
Date
|
|
/s/ John Leone - for PineBridge Global Emerging Markets Partners II, L.P., By: PineBridge GEM II GP Ltd., its GP, By PineBridge GEM II G.P., L.P., its sole director, By PineBridge GEM II G.P., Co., its GP, By: John Leone, Vice President
|
2024-09-17
|
|
**Signature of Reporting Person
|
Date
|
|
/s/ John Leone
|
2024-09-17
|
|
**Signature of Reporting Person
|
Date
|
|
/s/ Lindsay Johnson - as Attorney-in-Fact for Kevin Clowe
|
2024-09-17
|
|
**Signature of Reporting Person
|
Date
|
|
/s/ Lindsay Johnson - as Attorney-in-Fact for Pierre Mellinger
|
2024-09-17
|
|
**Signature of Reporting Person
|
Date
|
Explanation of Responses:
|
(*)
|
If the form is filed by more than one reporting person, see Instruction 5(b)(v).
|
|
(**)
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
|
(1)
|
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by PineBridge Global Emerging Markets Partners II, L.P., a Cayman Islands limited partnership ("GEM II"), on June 14, 2024.
|
|
(2)
|
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.00 to $19.46, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
|
|
(3)
|
This is a joint filing by GEM II, PineBridge GEM II G.P., L.P., a Cayman Islands limited partnership ("GEM II GP"), John Leone, Kevin Clowe and Pierre Mellinger. The reported shares are held directly by GEM II. GEM II GP is the sole director of PineBridge GEM II GP Ltd., which is the sole general partner of GEM II. Mr. Leone, Mr. Clowe and Mr. Mellinger serve on the three-member investment committee of GEM II GP, which manages the investment activities of GEM II.
|
|
(4)
|
GEM II GP, Mr. Leone, Mr. Clowe and Mr. Mellinger disclaim beneficial ownership of the reported securities except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission of beneficial ownership of the securities for purposes of Section 16 or any other purpose.
|
|
(5)
|
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.95 to $20.45, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
|
|
(6)
|
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.48 to $20.115, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
|
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
See Instruction 6 for procedure.Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
